Ingrid Hopper

Summary

Affiliation: Monash University
Country: Australia

Publications

  1. doi Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient elastography
    Ingrid Hopper
    Department of Clinical Pharmacology and Therapeutics, The Alfred Center, Melbourne, Australia
    Eur J Heart Fail 14:621-7. 2012
  2. doi Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm
    Ingrid Hopper
    Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
    Eur J Heart Fail 15:69-78. 2013
  3. ncbi Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients
    Kah Yong Peck
    Department of Clinical Pharmacology, Alfred Hospital, Melbourne, Australia
    Int J Cardiol 173:197-203. 2014
  4. doi Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction
    Hannah Clark
    Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Victoria, 3004, Australia
    Eur J Heart Fail 16:41-8. 2014
  5. doi Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials
    Ingrid Hopper
    Department of Clinical Pharmacology, Alfred Hospital, Melbourne, Australia
    Eur J Cardiovasc Prev Rehabil 18:813-23. 2011

Collaborators

Detail Information

Publications5

  1. doi Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient elastography
    Ingrid Hopper
    Department of Clinical Pharmacology and Therapeutics, The Alfred Center, Melbourne, Australia
    Eur J Heart Fail 14:621-7. 2012
    ..We examined the impact of cardiac dysfunction on LSM using FibroScan(®) and the influence of volume changes on LSM...
  2. doi Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm
    Ingrid Hopper
    Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
    Eur J Heart Fail 15:69-78. 2013
    ..We conducted an updated meta-analysis comparing these medications on outcomes in HF...
  3. ncbi Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients
    Kah Yong Peck
    Department of Clinical Pharmacology, Alfred Hospital, Melbourne, Australia
    Int J Cardiol 173:197-203. 2014
    ..We therefore conducted a meta-analysis comparing the effect on SCD achieved by ICDs versus medical therapies, additional to standard background medical therapies including ACE inhibitors and/or beta-blockers (BBs)...
  4. doi Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction
    Hannah Clark
    Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Victoria, 3004, Australia
    Eur J Heart Fail 16:41-8. 2014
    ..It is not clear whether worsening renal function (WRF) in patients exposed to these agents predicts a worse prognosis or merely reflects the pharmacological action of the drug on the kidney...
  5. doi Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials
    Ingrid Hopper
    Department of Clinical Pharmacology, Alfred Hospital, Melbourne, Australia
    Eur J Cardiovasc Prev Rehabil 18:813-23. 2011
    ..We therefore sought to determine whether interventions (including diet, exercise and pharmacological therapy), altered all-cause and cardiovascular related mortality in such subjects...